140 related articles for article (PubMed ID: 37902259)
41. Essential medicines for cancer: WHO recommendations and national priorities.
Robertson J; Barr R; Shulman LN; Forte GB; Magrini N
Bull World Health Organ; 2016 Oct; 94(10):735-742. PubMed ID: 27843163
[TBL] [Abstract][Full Text] [Related]
42. Evaluating essential medicines for treating childhood cancers: availability, price and affordability study in Ghana.
Mensah KB; Mensah ABB; Bangalee V; Padayachee N; Oosthuizen F
BMC Cancer; 2021 Jun; 21(1):683. PubMed ID: 34112117
[TBL] [Abstract][Full Text] [Related]
43. Essential Medicines at the National Level: The Global Asthma Network's Essential Asthma Medicines Survey 2014.
Bissell K; Ellwood P; Ellwood E; Chiang CY; Marks GB; El Sony A; Asher I; Billo N; Perrin C;
Int J Environ Res Public Health; 2019 Feb; 16(4):. PubMed ID: 30791442
[TBL] [Abstract][Full Text] [Related]
44. Use of non-steroidal anti-inflammatory drugs that elevate cardiovascular risk: an examination of sales and essential medicines lists in low-, middle-, and high-income countries.
McGettigan P; Henry D
PLoS Med; 2013; 10(2):e1001388. PubMed ID: 23424288
[TBL] [Abstract][Full Text] [Related]
45. Evaluation of prices, availability and affordability of essential medicines in Lahore Division, Pakistan: A cross-sectional survey using WHO/HAI methodology.
Saeed A; Saeed H; Saleem Z; Fang Y; Babar ZU
PLoS One; 2019; 14(4):e0216122. PubMed ID: 31022276
[TBL] [Abstract][Full Text] [Related]
46. Accessibility of essential anticancer medicines for children in the Sichuan Province of China.
Chen Z; Li S; Zou K; Li H; Zeng L; Lu X; Jia ZJ; Cheng G; Zhang L
Front Public Health; 2022; 10():980969. PubMed ID: 36408013
[TBL] [Abstract][Full Text] [Related]
47. The role of health systems factors in facilitating access to psychotropic medicines: a cross-sectional analysis of the WHO-AIMS in 63 low- and middle-income countries.
McBain R; Norton DJ; Morris J; Yasamy MT; Betancourt TS
PLoS Med; 2012 Jan; 9(1):e1001166. PubMed ID: 22303288
[TBL] [Abstract][Full Text] [Related]
48. The availability of essential medicines for diabetes at health facilities in Bangladesh: evidence from 2014 and 2017 national surveys.
Hakim S; Chowdhury MAB; Ahmed NU; Uddin MJ
BMC Health Serv Res; 2022 Mar; 22(1):377. PubMed ID: 35317808
[TBL] [Abstract][Full Text] [Related]
49. Availability and affordability of essential medicines for diabetes across high-income, middle-income, and low-income countries: a prospective epidemiological study.
Chow CK; Ramasundarahettige C; Hu W; AlHabib KF; Avezum A; Cheng X; Chifamba J; Dagenais G; Dans A; Egbujie BA; Gupta R; Iqbal R; Ismail N; Keskinler MV; Khatib R; Kruger L; Kumar R; Lanas F; Lear S; Lopez-Jaramillo P; McKee M; Mohammadifard N; Mohan V; Mony P; Orlandini A; Rosengren A; Vijayakumar K; Wei L; Yeates K; Yusoff K; Yusuf R; Yusufali A; Zatonska K; Zhou Y; Islam S; Corsi D; Rangarajan S; Teo K; Gerstein HC; Yusuf S;
Lancet Diabetes Endocrinol; 2018 Oct; 6(10):798-808. PubMed ID: 30170949
[TBL] [Abstract][Full Text] [Related]
50. Availability and prices of medicines for non-communicable diseases at health facilities and retail drug outlets in Kenya: a cross-sectional survey in eight counties.
Ashigbie PG; Rockers PC; Laing RO; Cabral HJ; Onyango MA; Buleti JPL; Wirtz VJ
BMJ Open; 2020 May; 10(5):e035132. PubMed ID: 32414824
[TBL] [Abstract][Full Text] [Related]
51. Bridging the gap? Local production of medicines on the national essential medicine lists of Kenya, Tanzania and Uganda.
Baldeh AO; Millard C; Pollock AM; Brhlikova P
J Pharm Policy Pract; 2023 Jan; 16(1):18. PubMed ID: 36717871
[TBL] [Abstract][Full Text] [Related]
52. Availability, prices and affordability of the World Health Organization's essential medicines for children in Guatemala.
Anson A; Ramay B; de Esparza AR; Bero L
Global Health; 2012 Jul; 8():22. PubMed ID: 22747646
[TBL] [Abstract][Full Text] [Related]
53. An Analysis of Accessibility of Representative Psychotropic Medicine From the World Health Organization Model List of Essential Medicines in Developing Countries With Different Income Levels.
Shi Y; Zhang L; Fu J; Shao R; Yan J
Value Health; 2023 Apr; 26(4):528-535. PubMed ID: 36442833
[TBL] [Abstract][Full Text] [Related]
54. Global, regional and national availability of essential medicines for children, 2009-2020: a systematic review and meta-analysis.
Shi Y; Chen Z; Zou K; Zhang M; Liu Z; Liu D; Zeng L; Li H; Jia ZJ; Cheng G; Tang Y; Zhao S; Jiang Y; Choonara I; Zhang L
BMC Public Health; 2023 Jun; 23(1):1185. PubMed ID: 37340382
[TBL] [Abstract][Full Text] [Related]
55. Access to medicines through health systems in low- and middle-income countries.
Ozawa S; Shankar R; Leopold C; Orubu S
Health Policy Plan; 2019 Dec; 34(Supplement_3):iii1-iii3. PubMed ID: 31816069
[TBL] [Abstract][Full Text] [Related]
56. Availability of Access, Watch, and Reserve groups of essential antibiotics: a cross-sectional survey.
Rafi S; Anjum SM; Usman M; Nawaz HA; Chaudhry M; Babar ZU; Rasheed H
Front Public Health; 2023; 11():1251434. PubMed ID: 38239798
[TBL] [Abstract][Full Text] [Related]
57. Universal access to essential medicines as part of the right to health: a cross-national comparison of national laws, medicines policies, and health system indicators.
Perehudoff K
Glob Health Action; 2020 Dec; 13(1):1699342. PubMed ID: 33131456
[TBL] [Abstract][Full Text] [Related]
58. Access to essential cardiovascular medicines for children: a pilot study of availability, price and affordability in Nigeria.
Orubu ESF; Robert FO; Samuel M; Megbule D
Health Policy Plan; 2019 Dec; 34(Supplement_3):iii20-iii26. PubMed ID: 31816074
[TBL] [Abstract][Full Text] [Related]
59. Availability of Essential Medicines for Pediatric Oncology in Armenia.
Simonyan T; Papyan R; Danielyan S; Sargsyan L; Grigoryan V; Topchyan H; Azaryan A; Tananyan A; Muradyan A; Tamamyan G
Asian Pac J Cancer Prev; 2019 Apr; 20(4):991-994. PubMed ID: 31030465
[TBL] [Abstract][Full Text] [Related]
60. Availability of essential medicines, progress and regional distribution in China: a systematic review and meta-analysis.
Zhang M; Zou K; Liu Z; Liu D; Wang X; Shi Y; Chen Z; Cheng X; Lang B; Li H; Zeng L; Tang Y; Zhao S; Jiang Y; Choonara I; Zhang L
Front Public Health; 2023; 11():1149838. PubMed ID: 37181691
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
